Nirsevimab

IF 0.8 Q4 PHARMACOLOGY & PHARMACY

Hospital Pharmacy Pub Date : 2023-11-19 DOI:10.1177/00185787231212620

Terri L. Levien, Danial E. Baker

引用次数: 0

Abstract

Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing in-services. A comprehensive target drug utilization evaluation/medication use evaluation (DUE/MUE) is also provided each month. With a subscription, the monographs are available online to subscribers. Monographs can be customized to meet the needs of a facility. Through the cooperation of The Formulary, Hospital Pharmacy publishes selected reviews in this column. For more information about The Formulary Monograph Service, contact Wolters Kluwer customer service at 866-397-3433.

查看原文本刊更多论文

Nirsevimab

每月，《处方集专论服务》的订户都会收到 5 到 6 篇有据可查的专论，内容涉及新上市或处于 3 期试验后期的药物。这些专论主要针对药学和治疗学委员会。订户每月还会收到 1 页的药剂摘要专论，这些专论对议程和药学/护理培训很有用。此外，每月还会提供一份全面的目标药物使用评估/用药评估 (DUE/MUE)。订阅者可在线获取各论。各论可根据医疗机构的需求进行定制。通过与《处方集》的合作，医院药房在本专栏中发表了部分评论。有关《处方集》专论服务的更多信息，请致电 866-397-3433 联系 Wolters Kluwer 客户服务。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Hospital Pharmacy PHARMACOLOGY & PHARMACY-

CiteScore

1.70

自引率

0.00%

发文量

期刊介绍： Hospital Pharmacy is a monthly peer-reviewed journal that is read by pharmacists and other providers practicing in the inpatient and outpatient setting within hospitals, long-term care facilities, home care, and other health-system settings The Hospital Pharmacy Assistant Editor, Michael R. Cohen, RPh, MS, DSc, FASHP, is author of a Medication Error Report Analysis and founder of The Institute for Safe Medication Practices (ISMP), a nonprofit organization that provides education about adverse drug events and their prevention.